US FDA warns of increased myopathy risk with Zocor

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

U.S. Food and Drug Administration.FDA Warns About Increased Risk of Muscle Injury with Zocor. Media Release: 19 Mar 2010. Available from: URL: http://www.fda.gov
FDA.FDA Drug Safety Communications: ongoing safety review of high-dose Zocor* (simvastatin) and increased risk of muscle injury. Internet Document: [3 pages], 19 Mar 2010. Available from: URL: http://www.fda.gov

US FDA warns of increased myopathy risk with Zocor. React. Wkly. 1294, 1 (2010). https://doi.org/10.2165/00128415-201012940-00001

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.